Skip to main content

MoneyWorks4Me

The quarter ended September 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 18680.00 millions.Net profit declined -29.77% to Rs. 3420.00 millions from Rs. 4870.00 millions.The Operating Profit of the company witnessed a decrease to 5590.00 millions from 6880.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 18680.00 18230.00 2.47 35980.00 40270.00 -10.65 76253.00 88798.20 -14.13
Other Income 850.00 790.00 7.59 1650.00 1690.00 -2.37 3490.10 1112.60 213.69
PBIDT 5590.00 6880.00 -18.75 11300.00 16150.00 -30.03 26966.90 39877.20 -32.38
Interest 10.00 0.00 0.00 10.00 0.00 0.00 5.20 6.50 -20.00
PBDT 5580.00 6880.00 -18.90 11290.00 16150.00 -30.09 26961.70 39870.70 -32.38
Depreciation 940.00 850.00 10.59 1870.00 1680.00 11.31 3420.70 3105.50 10.15
PBT 4640.00 6030.00 -23.05 9420.00 14470.00 -34.90 23541.00 36765.20 -35.97
TAX 1220.00 1160.00 5.17 2550.00 2690.00 -5.20 5459.50 7279.80 -25.00
Deferred Tax 140.00 260.00 -46.15 240.00 410.00 -41.46 1083.70 907.80 19.38
PAT 3420.00 4870.00 -29.77 6870.00 11780.00 -41.68 18081.50 29485.40 -38.68
Equity 530.00 530.00 0.00 530.00 530.90 -0.17 530.90 530.90 0.00
PBIDTM(%) 29.93 37.74 -20.71 31.41 40.10 -21.69 35.37 44.91 -21.25
Peers
Company Name CMP
Sun Pharma. Inds. 1747.95
Dr. Reddys Labs. 1355.70
Cipla 1378.60
Lupin 2008.45
Zydus Lifesciences 1238.00
View more..